KY commission weighing investment in psychedelic to treat addiction hears from detractors

“It does have a certain attractiveness to think if you could give a single dose of a drug, that could give a lifetime cure,” said Dr. Mark Haigney, but, “My opinion is ibogaine is not safe.”

Related Keywords

Kentucky ,United States ,University Of Kentucky ,National Institutes Of Health ,Maryland ,United Kingdom ,Kentuckians ,Patricia Freeman ,Robert Walsh ,Daniel Cameron ,Mark Haigney ,Sharon Walsh ,Rick Doblin ,Vic Brown ,Bryan Hubbard ,Alcohol Research ,Regulatory Affairs Branch ,Multidisciplinary Association For Psychedelic ,Drug Administration ,National Institute On Drug Abuse ,United Kingdom Center On Drug ,Division Of Therapeutics ,Kentucky Opioid Abatement Advisory Commission ,College Of Pharmacy ,Military Cardiovascular Outcomes Research ,Walter Reed National Military Medical Center ,Chair Bryan Hubbard ,West Central Africa ,National Institute ,Drug Abuse ,Republican Attorney General Daniel Cameron ,Both Freeman ,National Institutes ,Medical Consequences ,Multidisciplinary Association ,Psychedelic Studies ,Commission Members ,Opioid Addiction ,Psychedelic Drug ,Clinical Research ,He Commission ,Food And Drug Administration ,